Contact
Please use this form to send email to PR contact of this press release:
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
TO:
Please use this form to send email to PR contact of this press release:
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
TO: